IDEVvsXPH
iShares Core MSCI International Developed Markets ETF against SPDR S&P Pharmaceuticals ETF — the fee, the flows, the book, and a year head-to-head.
Head to head
| IDEV | XPH | |
|---|---|---|
| Expense ratio | 0.040% | 0.35% |
| Assets | $32.4B | $487M |
| Net flow, 1 month | +$828M | −$69M |
| Net flow, 1 year | +$6.8B | +$254M |
| Return, YTD | +8.9% | +12.3% |
| Return, 1 year | +10.0% | +29.4% |
| Avg daily volume | 2.6M | 205K |
| Holdings | 2281 | 41 |
| Listed | Mar 21, 2017 | Jun 19, 2006 |
| Options market | Yes | Yes |
MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS